Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Publishing timestamp: 2025-01-17 13:06:42
Summary
The Biden administration unveiled the next 15 prescription drugs subject to price negotiations with Medicare, including popular medications like Ozempic and Wegovy. The move aims to make costly medications more affordable for seniors, but faces opposition from pharmaceutical companies. The negotiations are part of the Inflation Reduction Act and are expected to save Medicare enrollees billions in out-of-pocket costs.
Sentiment: MIXED
Tickers: TEVA, IRWD, TBPH, LLY, GSK, NVO, BMY, NOVO.B-DK, PFE, AZN, MRK, AMGN, ABBV,
Keywords: prices, biotech and pharmaceuticals, business news, astrazeneca plc, health care industry, teva pharmaceutical industries ltd, joe biden, seniors' health, medicare, pfizer inc, bristol-myers squibb co, merck & co inc, social issues, abbvie inc, business, health care costs, biotechnology, retiree finances, amgen inc, gsk plc, theravance biopharma inc, breaking news: business, ironwood pharmaceuticals inc, pharmaceuticals, lilly drn, centers for medicare & medicaid services, novo nordisk a/s,
Source: https://www.cnbc.com/2025/01/17/medicare-drug-price-negotiations-list-includes-ozempic.html